Hep Email Update Revolutionary Advances in Liver Disease Research Unveiled at EASL Congress 2024 Researchers will present new research on MASLD, viral hepatitis, advanced cirrhosis, liver transplantation and more. EASL Congress 2024: Combating Liver Disease Collectively 90% of liver disease cases can be prevented, but this requires commitment, comprehensive solutions and collaboration. Bulevirtide Plus Pegylated Interferon Can Maintain Undetectable Hepatitis D People who used the combination regimen were more likely to still have an undetectable HDV load a year after stopping treatment. Advertisement What Is Fatty Liver Disease? (MASLD and MASH) Learn the latest about fatty liver. What Is Hepatitis C? Get the basics! Hepatitis C Survey Tell us about your experience with hepatitis C. Advertisement Science News Bulevirtide Plus Pegylated Interferon Can Maintain Undetectable Hepatitis D Revolutionary Advances in Liver Disease Research Unveiled at EASL Congress 2024 Armored CAR-T Therapy Shows Promise for Liver Cancer High H5N1 Influenza Levels Found in Mice Given Raw Milk From Infected Dairy Cows Newsfeed EASL Congress 2024: Combating Liver Disease Collectively CDC Confirms Second Human H5 Bird Flu Case in Michigan New Liver Transplant Policy Raises Concerns About Increased Costs and Equity Proposed 5-Year Program Aims to Put Country on the Path to Eliminating Hepatitis C Science News Bulevirtide Plus Pegylated Interferon Can Maintain Undetectable Hepatitis D Revolutionary Advances in Liver Disease Research Unveiled at EASL Congress 2024 Armored CAR-T Therapy Shows Promise for Liver Cancer High H5N1 Influenza Levels Found in Mice Given Raw Milk From Infected Dairy Cows Newsfeed EASL Congress 2024: Combating Liver Disease Collectively CDC Confirms Second Human H5 Bird Flu Case in Michigan New Liver Transplant Policy Raises Concerns About Increased Costs and Equity Proposed 5-Year Program Aims to Put Country on the Path to Eliminating Hepatitis C

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to [email protected] by [email protected]. Please remember to add [email protected] to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: